CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression

被引:13
|
作者
McCloskey, TW
Oyaizu, N
Bakshi, S
Kowalski, R
Kohn, N
Pahwa, S
机构
[1] NYU, N Shore Univ Hosp, Sch Med, Dept Pediat,Div Allergy Immunol, Manhasset, NY 11030 USA
[2] NYU, N Shore Univ Hosp, Sch Med, Dept Res,Div Biostat, Manhasset, NY 11030 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 87卷 / 01期
基金
美国国家卫生研究院;
关键词
CD95; apoptosis; HIV; infants;
D O I
10.1006/clin.1997.4496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pediatric HIV infection is characterized by a progressive decline in CD4 T lymphocytes and faster disease progression than is typically seen in adults. Apoptosis, possibly mediated through the CD95 antigen, has been proposed as a mechanism for cell loss which eventually leads to immune dysfunction. In this study of peripheral blood lymphocytes from HIV-infected children, classified according to CDC immunologic categories, we found that the percentage of CD4 and CD8 T cells expressing CD95 and the percentage of lymphocytes undergoing apoptosis were increased in children with HIV infection and were greater in children from immunologic Category III as compared to those in Category I. Most striking was our observation that an increased percentage of CD95-positive cells appeared as early as 3 months of age, at a time when these children did not have elevated levels of apoptosis. These data demonstrate early upregulation of CD95 expression in HIV-infected infants, an abberation which may have profound implications for the pathogenesis of perinatally acquired IIIV disease. (C) 1998 Academic Press.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [41] Role of CD95 in pulmonary inflammation and infection in cystic fibrosis
    Becker, Katrin Anne
    Henry, Brian
    Ziobro, Regan
    Tuemmler, Burkhard
    Gulbins, Erich
    Grassme, Heike
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (09): : 1011 - 1023
  • [42] Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
    Müschen, M
    Re, D
    Betz, B
    Moers, C
    Wolf, J
    Niederacher, D
    Diehl, V
    Beckmann, MW
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) : 309 - 310
  • [43] CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity
    Jekle, A
    Obst, R
    Lang, F
    Rammensee, HG
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 395 - 399
  • [44] CD95 expression and function on lymphocyte subpopulations in common variable immunodeficiency (CVID); related to increased apoptosis
    Iglesias, J
    Matamoros, N
    Raga, S
    Ferrer, JM
    Mila, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 117 (01) : 138 - 146
  • [45] CD95/CD95L interactions and their role in autoimmunity
    Ricci-Vitiani, L
    Conticello, C
    Zeuner, A
    De Maria, R
    APOPTOSIS, 2000, 5 (05) : 419 - 424
  • [46] CD95/CD95L interactions and their role in autoimmunity
    L. Ricci-Vitiani
    C. Conticello
    A. Zeuner
    R. De Maria
    Apoptosis, 2000, 5 : 419 - 424
  • [47] CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice
    A. Signore
    A. Annovazzi
    E. Procaccini
    P. E. Beales
    J. Spencer
    R. Testi
    G. Ruberti
    Diabetologia, 1997, 40 : 1476 - 1479
  • [48] CD95 polymorphisms are associated with susceptibility to MS in women -: A population-based study of CD95 and CD95L in MS
    Kantarci, OH
    Hebrink, DD
    Achenbach, SJ
    Atkinson, EJ
    de Andrade, M
    McMurray, CT
    Weinshenker, BG
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 146 (1-2) : 162 - 170
  • [49] Fas (CD95)/FasL (CD178) system during ageing
    Lagunas-Rangel, Francisco A.
    CELL BIOLOGY INTERNATIONAL, 2023, 47 (08) : 1295 - 1313
  • [50] Regulation of CD95/Fas signaling at the DISC
    I N Lavrik
    P H Krammer
    Cell Death & Differentiation, 2012, 19 : 36 - 41